|
|
||||||||
in the evolution of murine bleomycin lung fibrosis
1Lung Cellular & Molecular Biology Laboratory, Institute of Pulmonology, 2Bone Marrow Transplantation Department, Hadassah University Hospital and Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel; and 3Mallory Institute of Pathology, Department of Pathology and Laboratory Medicine, Boston University School of Medicine, Boston, Massachusetts 02118
Submitted 14 September 2002 ; accepted in final form 27 June 2003
IFN-
production is upregulated in lung cells (LC) of bleomycin-treated C57BL/6 mice. The present study characterizes the time course, cellular source, and regulation of IFN-
expression in bleomycin-induced lung injury. IFN-
mRNA in LC from bleomycin-treated mice peaked 3 days after intratracheal instillation. IFN-
protein levels were increased at 6 days, as was the percentage of LC expressing IFN-
. CD4+, CD8+, and natural killer cells each contributed significantly to IFN-
production. IL-12 mRNA levels were increased at 1 day in LC of bleomycin-treated mice. Anti-IL-12 and anti-IL-18 antibodies decreased IFN-
production by these cells. To define the role of endogenous IFN-
in the evolution of bleomycin lung injury, we compared the effect of bleomycin in mice with a targeted knockout mutation of the IFN-
gene (IFN-
knockout) and wild-type mice. At 14 days after intratracheal bleomycin, total bronchoalveolar lavage cell counts and lung hydroxyproline were decreased in IFN-
knockouts compared with wild-type animals. There was no difference in morphometric parameters of fibrosis. Our data show that enhanced IFN-
production in the lungs of bleomycin-treated mice is at least partly IL-12 and IL-18 dependent. Absence of IFN-
in IFN-
knockout mice does not increase pulmonary fibrosis. Endogenous IFN-
may play a proinflammatory or profibrotic role in bleomycin-induced lung fibrosis.
interstitial lung disease; transgenic/knockout; cytokines
This article has been cited by other articles:
![]() |
R. Golan-Gerstl, S. B. Wallach-Dayan, G. Amir, and R. Breuer Epithelial Cell Apoptosis by Fas Ligand-Positive Myofibroblasts in Lung Fibrosis Am. J. Respir. Cell Mol. Biol., March 1, 2007; 36(3): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, A. L. Mora, J. LaVoy, K. L. Brigham, and M. Rojas Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L658 - L667. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mora, C. R. Woods, A. Garcia, J. Xu, M. Rojas, S. H. Speck, J. Roman, K. L. Brigham, and A. A. Stecenko Lung infection with {gamma}-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L711 - L721. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamada, H. Kubo, S. Kobayashi, K. Ishizawa, and H. Sasaki Interferon-{gamma}: a key contributor to hyperoxia-induced lung injury in mice Am J Physiol Lung Cell Mol Physiol, November 1, 2004; 287(5): L1042 - L1047. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |